Central Diabetes Insipidus: An Acute Manifestation of COVID-19 Infection

Sharanya Suresh Kumar; Kiran Kumar; Sneha Venkataramani; Naail Mohammed Ghazi

doi:10.7759/cureus.43884

Central Diabetes Insipidus: An Acute Manifestation of COVID-19 Infection

Cureus. 2023 Aug 21;15(8):e43884. doi: 10.7759/cureus.43884. eCollection 2023 Aug.

Authors

Sharanya Suresh Kumar¹, Kiran Kumar², Sneha Venkataramani³, Naail Mohammed Ghazi³

Affiliations

¹ General Medicine, Thumbay University Hospital, Ajman, ARE.
² Internal Medicine, Thumbay University Hospital, Ajman, ARE.
³ College of Medicine, Gulf Medical University, Ajman, ARE.

Abstract

In recent years, there has been a rise in the number of COVID-19 cases and its complications. Central diabetes insipidus (central DI) is a rare but treatable manifestation of acute COVID-19 infection. This case reports the rapid onset of central DI in a 35-year-old male in less than two weeks post-COVID-19 infection. He made a complete recovery post-administration of desmopressin within one month. Prompt diagnosis, treatment, and periodic follow-up are hence the cornerstones of a successful recovery for a patient with central DI post-COVID-19 infection.

Keywords: central diabetes insipidus; covid-19; desmopressin; plasma osmolality; urine osmolality.

Publication types

Case Reports